product summary
company name :
Hycult Biotech
product type :
antibody
product name :
CD68, Rat, mAb ED1
catalog :
HM3029
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
ED1
reactivity :
rat
application :
western blot, immunohistochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
Hycult Biotech product webpage
citations: 13
Published Application/Species/Sample/DilutionReference
  • western blot; rat; 1:1000; fig 1
Yongping M, Zhang X, Xuewei L, Fan W, Chen J, Zhang H, et al. Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation. J Ethnopharmacol. 2015;169:200-9 pubmed publisher
  • immunohistochemistry; rat; loading ...; fig 3
Chandrupatla D, Weijers K, Gent Y, de Greeuw I, Lammertsma A, Jansen G, et al. Sustained macrophage infiltration upon multiple intra-articular injections: an improved rat model of rheumatoid arthritis for PET guided therapy evaluation. Biomed Res Int. 2015;2015:509295 pubmed publisher
Schreinemacher M, van Barneveld K, Dikmans R, Gijbels M, Greve J, Bouvy N. Coated meshes for hernia repair provide comparable intraperitoneal adhesion prevention. Surg Endosc. 2013;27:4202-9 pubmed publisher
Hirota K, Kawamoto T, Nakajima T, Makino K, Terada H. Distribution and deposition of respirable PLGA microspheres in lung alveoli. Colloids Surf B Biointerfaces. 2013;105:92-7 pubmed publisher
Dunn J, Wu Y, Zhao Z, Srinivasan S, Natah S. Training the brain to survive stroke. PLoS ONE. 2012;7:e45108 pubmed publisher
Misra Y, Bentley P, Bond J, Tighe S, Hunter T, Zhao F. Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis. Physiol Genomics. 2012;44:76-88 pubmed publisher
Folkersma H, Foster Dingley J, van Berckel B, Rozemuller A, Boellaard R, Huisman M, et al. Increased cerebral (R)-[(11)C]PK11195 uptake and glutamate release in a rat model of traumatic brain injury: a longitudinal pilot study. J Neuroinflammation. 2011;8:67 pubmed publisher
Linker R, Luhder F, Kallen K, Lee D, Engelhardt B, Rose John S, et al. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier. J Neuroimmunol. 2008;205:64-72 pubmed publisher
Bendszus M, Ladewig G, Jestaedt L, Misselwitz B, Solymosi L, Toyka K, et al. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study. Brain. 2008;131:2341-52 pubmed publisher
Yatkin E, Bernoulli J, Lammintausta R, Santti R. Fispemifene [Z-2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)-phenoxy]ethoxy}-ethanol], a novel selective estrogen receptor modulator, attenuates glandular inflammation in an animal model of chronic nonbacterial prostatitis. J Pharmacol Exp Ther. 2008;327:58-67 pubmed publisher
Mueller A, Pedre X, Stempfl T, Kleiter I, Couillard Despres S, Aigner L, et al. Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis. J Neuroinflammation. 2008;5:20 pubmed publisher
Merkler D, Ernsting T, Kerschensteiner M, Bruck W, Stadelmann C. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain. 2006;129:1972-83 pubmed
Wessig J, Brecht S, Claussen M, Roemer L, Goetz M, Bigini P, et al. Tumor necrosis factor-alpha receptor 1 (p55) knockout only transiently decreases the activation of c-Jun and does not affect the survival of axotomized dopaminergic nigral neurons. Eur J Neurosci. 2005;22:267-72 pubmed
product information
Catalog no :
HM3029
Title :
CD68, Rat, mAb ED1
Clone no :
ED1
Quantity :
100 µg
Application code :
frozen sections,flow cytometry,immunoprecipitation,paraffin sections,western blot
Species :
rat
Host species :
mouse
Isotype :
IgG1
Conjugate :
purified
Aliases :
Macrosailin
Type :
mAb
Antigen :
CD68, Macrosailin
Meta data :
Macrosailin
more info or order :
Hycult Biotech product webpage
company information
Hycult Biotech
Frontstraat 2a
5405 PB UDEN
support@hycultbiotech.com
www.hycultbiotech.com
31 0 413 25 13 35
headquarters: Netherlands
Hycult Biotech develops, produces and markets antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.

As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.